Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y H Joshua Chen

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|March 23, 2012
Testing superiority at interim analyses in a non-inferiority trialY H Joshua Chen, Cong Chen
Journal of Biopharmaceutical Statistics|July 9, 2008
On methods to utilize HIV-RNA data measured by two different PCR assaysY H Joshua Chen, Chunpeng Fan, Jing Zhao
Journal of Biopharmaceutical Statistics|May 27, 2006
Testing for crossover of two hazard functions using Gail and Simon's methodY H Joshua Chen, G H Frank Liu
Clinical Trials (London, England)|October 4, 2014
A seamless phase IIB/III adaptive outcome trial: design rationale and implementation challengesY H Joshua Chen, Richard Gesser, Alain Luxembourg
Journal of Biopharmaceutical Statistics|October 8, 2004
Incorporating durability information in the comparison of proportions of patients with HIV suppressionY H Joshua Chen, Michael L Nessly, Balasamy Thiyagarajan
Journal of Biopharmaceutical Statistics|August 30, 2017
Statistical inference following sample size adjustment based on the 50%-conditional-power principleY H Joshua Chen, Shuai S Yuan, Xiaoming Li
Clinical Trials (London, England)|July 22, 2015
Sample size adjustment based on promising interim results and its application in confirmatory clinical trialsY H Joshua Chen, Caiyan Li, K K Gordon Lan
Statistics in Medicine|November 24, 2004
Treatment comparisons for a partially categorical outcome applied to a biomarker with assay limitY H Joshua Chen, A Lawrence Gould, Michael L Nessly
Statistics in Medicine|July 27, 2010
Some drop-the-loser designs for monitoring multiple dosesY H Joshua Chen, David L Demets, K K Gordon Lan
Controlled Clinical Trials|February 1, 2003
Monitoring mortality at interim analyses while testing a composite endpoint at the final analysisY H Joshua Chen, David L DeMets, K K Gordon Lan
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|March 23, 2012
Testing superiority at interim analyses in a non-inferiority trialY H Joshua Chen, Cong Chen
Journal of Biopharmaceutical Statistics|July 9, 2008
On methods to utilize HIV-RNA data measured by two different PCR assaysY H Joshua Chen, Chunpeng Fan, Jing Zhao
Journal of Biopharmaceutical Statistics|May 27, 2006
Testing for crossover of two hazard functions using Gail and Simon's methodY H Joshua Chen, G H Frank Liu
Clinical Trials (London, England)|October 4, 2014
A seamless phase IIB/III adaptive outcome trial: design rationale and implementation challengesY H Joshua Chen, Richard Gesser, Alain Luxembourg
Journal of Biopharmaceutical Statistics|October 8, 2004
Incorporating durability information in the comparison of proportions of patients with HIV suppressionY H Joshua Chen, Michael L Nessly, Balasamy Thiyagarajan
Journal of Biopharmaceutical Statistics|August 30, 2017
Statistical inference following sample size adjustment based on the 50%-conditional-power principleY H Joshua Chen, Shuai S Yuan, Xiaoming Li
Clinical Trials (London, England)|July 22, 2015
Sample size adjustment based on promising interim results and its application in confirmatory clinical trialsY H Joshua Chen, Caiyan Li, K K Gordon Lan
Statistics in Medicine|November 24, 2004
Treatment comparisons for a partially categorical outcome applied to a biomarker with assay limitY H Joshua Chen, A Lawrence Gould, Michael L Nessly
Statistics in Medicine|July 27, 2010
Some drop-the-loser designs for monitoring multiple dosesY H Joshua Chen, David L Demets, K K Gordon Lan
Controlled Clinical Trials|February 1, 2003
Monitoring mortality at interim analyses while testing a composite endpoint at the final analysisY H Joshua Chen, David L DeMets, K K Gordon Lan
Pageof 2